The variability of the Cypor level depends on the nature of the tissue samples
https://doi.org/10.52419/issn2072-2419.2025.3.223
Abstract
A significant number of CYP450 enzymes of the mammalian body are localized in hepatocytes, which determines the high metabolic capacity of the liver in relation to most foreign substances. Due to the fact that there are no data in the scientific literature on the concentration of CYP450 in the body of laboratory rats depending on the nature of tissue samples, the main goal of our study included studying the variability of the CYPOR concentration level in various biomaterials (blood serum, liver homogenates). Several groups of laboratory rats weighing 180-195 g, of both sexes (n = 20) were formed for the study. At the end of the quarantine, the laboratory rats were humanely euthanized (LEC at the FSBEI HE SPbSUVM, protocol No. 2, dated 04/20/2025) in order to obtain liver homogenate. For this purpose, the samples were placed in a special suspension medium for tissue homogenization (pH=7.4; the basis of the medium is Tris-HCl buffer with the addition of 0.25 M sucrose and a small amount of ethylenediaminetetraacetic acid and sodium salt in order to bind divalent metal ions and glutathione to prevent peroxidation of lipid components. Then, using a homogenizer (Stegler S10, China), 20 homogenate samples were obtained (1 g of tissue per 9 ml of the above medium), which were analyzed by enzyme immunoassay. As a result of the study, the results obtained in the blood serum were statistically unreliable, and amounted to figures in the range from 0 to 470 ng / ml, and often went beyond the sensitivity of the determination method. In the liver homogenates, there was an opposite picture, where the range was from 0.650 to 11.8 ng / ml, the data were representative, reliable.
About the Authors
O. S. PopovaRussian Federation
Ph.D. of Veterinary Science, Associate Professor Pharmacology and Toxicology
D. S. Bylinskaya
Russian Federation
PhD of veterinary science, Associate Professor Animal Anatomy
References
1. Activity of NAD(P)H-Oxidoreductases in Ovarian Cancer / M. V. Fedorova, V. I. Voznesensky, E. A. Sosnova, E. V. Proskurnina // Biomedicines. – 2024. – Vol. 12, No. 5. – P. 1052. – DOI 10.3390/biomedicines12051052.
2. Ponomarev, V. S. Nonlinear elimination of pharmaceutical substances in multicompartment and non-compartment pharmacokinetic models / V. S. Ponomarev // Normative and legal regulation in veterinary medicine. – 2022. – No. 3. – P. 70-73. – DOI 10.52419/issn2782-6252.2022.3.70.
3. Ponomarev, V. S. Possibilities of prognostic toxicology in assessing the potential hepatotoxicity of drugs / V. S. Ponomarev, A. M. Lunegov // Normative and legal regulation in veterinary medicine. – 2022. – No. 1. – P. 64-67. – DOI 10.52419/issn2782-6252.2022.1.64.
4. Ponomarev, V. S. Prospects of metabolomic approaches in toxicological studies / V. S. Ponomarev // Normative and legal regulation in veterinary medicine. – 2022. – No. 3. – P. 78-81. – DOI 10.52419/issn2782-6252.2022.3.78.
5. Ponomarev, V. S. Nonlinear elimination of pharmaceutical substances in single-compartment pharmacokinetic models / V. S. Ponomarev // Normative-legal regulation in veterinary medicine. - 2022. - No. 2. - P. 90- 92. - DOI 10.52419/issn2782-6252.2022.2.90.
6. Biosensor selection of low-molecular compounds that modulate interactions in the system of microsomal cytochromes P450 and NADPH-dependent P450 oxidoreductase / P. V. Ershov, E. O. Yablokov, Yu. V. Mezentsev [et al.] // Biomedical Chemistry: Research and Methods. - 2020. - Vol. 3, No. 3. - P. e00134. - DOI 10.18097/BMCRM00134.
7. The effect of changes in the activity of cytochrome P450 2e1 in the liver on the toxic properties and carcinogenicity of diethylnitrosamine in mice / V. I. Kaledin, S. I. Ilnitskaya, E. A. Vasunina [et al.] // Biophysics. – 2015. – Vol. 60, No. 6. – P. 1166- 1173.
8. Chernyak, Yu. I. Cytochrome P450: Basic Concepts, Research Methods, and Significance for Practical Medicine / Yu. I. Chernyak, S. I. Kolesnikov, E. V. Chernyak. – 2nd edition, revised. – Irkutsk: Irkutsk State University, 2014. – 47 p. – ISBN 978-5-9624-0996-2.
9. Masters, B. S. Cytochromes P450 - A family of proteins and scientists-understanding their relationships / B. S. Masters, C. C. Marohnic // Drug Metabolism Reviews. – 2006. – Vol. 38, No. 1-2. – P. 209-225. – DOI 10.1080/03602530600570065.
10. Structure and function of an NADPHcytochrome P450 oxidoreductase in an open conformation capable of reducing cytochrome P450 / D. Hamdane, S. C. Im, H. Zhang [et al.] // Journal of Biological Chemistry. – 2009. – Vol. 284, No. 17. – P. 11374- 11384. – DOI 10.1074/jbc.M807868200.
11. Human cytochrome P450 oxidoreductase deficiency caused by the Y181D mutation: Molecular consequences and rescue of defect / C. C. Marohnic, S. P. Panda, K. McCammon [et al.] // Drug Metabolism and Disposition. – 2010. – Vol. 38, No. 2. – P. 332-340. – DOI 10.1124/dmd.109.030445.
12. Fedorova, M. V. Activity of microsomal reductases in ovarian cancer cells, intact and deficient in caspase-2 / M. V. Fedorova, M. A. Shestakova, E. V. Proskurnina // International Journal of Applied and Fundamental Research. – 2022. – No. 6. – P. 58-62. – DOI 10.17513/mjpfi.13398.
13. Identification and Functional Assessment of EightCYP3A4Allelic Variants*39– *46Detected in the Chinese Han Population / Yu. Qi, H. Yang, Sh. Wang [et al.] // Drug Metabolism and Disposition. – 2024. – Vol. 52, No. 3. – P. 218-227. – DOI 10.1124/dmd.123.001542.
14. Stimulation of de novo glutathione synthesis by nitrofurantoin for enhanced resilience of hepatocytes / L. S. Wijaya, C. Rau, T. S. Braun [et al.] // Cell Biology and Toxicology. – 2022. – Vol. 38, No. 5. – P. 847- 864. – DOI 10.1007/s10565-021-09610-3.
15. Oesch, F. Xenobiotica-metabolizing enzymes in the lung of experimental animals, man and in human lung models / F. Oesch, E. Fabian, R. Landsiedel // Archives of Toxicology. – 2019. – Vol. 93, No. 12. – P. 3419-3489. – DOI 10.1007/s00204-019-02602-7.
16. Co-expression of active human cytochrome P450 1A2 and cytochrome P450 reductase on the cell surface of Escherichia coli / P. Quehl, J. Hollender, J. Schüürmann [et al.] // Microbial Cell Factories. – 2016. – Vol. 15, No. 1. – P. 26. – DOI 10.1186/s12934-016-0427-5.
17. Vasilyeva S.V., Karpenko L.Yu., Dushenina O.A. Search for optimal methods of blood sampling from laboratory rats under chronic experimental conditions. Genetics and animal breeding. 2022;(4):56-60. DOI: 10.31043/2410-2733-2022-4-56-60
18. Dushenina, O.A. Analysis of methods of blood sampling from experimental rats Yu.A. Dushenina, L.Yu. Karpenko, S.V. Vasilyeva // Veterinary Science of Kuban. - 2022. - No. 6. - P. 21-24. 10.33861/2071- 8020 -20226-21-24. DOI: 10.33861/2071-8020-20226-21-24
Review
For citations:
Popova O.S., Bylinskaya D.S. The variability of the Cypor level depends on the nature of the tissue samples. International Journal of Veterinary Medicine. 2025;(3):223-230. (In Russ.) https://doi.org/10.52419/issn2072-2419.2025.3.223
JATS XML


















